Data Foundry

Drug recalls 2021

Rizatriptan Benzoate Orally Disintegrating Tablets 10mg — Class III drug recall D-0080-2022

Terminated recall by MACLEODS PHARMA USA, INC, reported 2021-11-03, distributed nationwide. Out-of-specification test results obtained in Organic Impurities test during analysis of controlled samples.

Recall numberD-0080-2022
Product typeDrug
ClassificationClass III
StatusTerminated
Voluntary or mandatedVoluntary
Recalling firmMACLEODS PHARMA USA, INC, Princeton, NJ, United States
Recall initiated2021-10-18
Classified2021-10-28
Reported by FDA2021-11-03
Terminated2024-04-24
DistributedNationwide (US)
Reason classesspecification failure
NDC33342-0093, 33342-0093-04, 33342-0093-07, 33342-0093-12, 33342-0093-23, 33342-0093-41, 33342-0093-45, 33342-0093-46, 33342-0093-48, 33342-0093-52, 33342-0093-72, 33342-0093-73, 33342-0094, 33342-0094-04, 33342-0094-07, 33342-0094-12, 33342-0094-23, 33342-0094-41, 33342-0094-45, 33342-0094-46, 33342-0094-47, 33342-0094-52, 33342-0094-72, 33342-0094-73
Lot numbersBRM2111A, BRM2112A, BRM2113A, BRM2114A, BRM2115A, BRM2116A
Expiration dates2025-04

Product

Rizatriptan Benzoate Orally Disintegrating Tablets 10mg, 18 Tablets (3 x 6 Unit-Dose Tablets) Blister Packs, Rx only, Manufactured for: Macleods Pharma USA Inc. Plainsboro, NJ 08536, Manufactured by: Macleods Pharmaceuticals Ltd. Baddi, Himachal Pradesh, INDIA, NDC 33342-094-41

Reason for recall

Out-of-specification test results obtained in Organic Impurities test during analysis of controlled samples.

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0080-2022. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.